Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06406777

Chronic Lung Allograft Dysfunction MRI Study

Validation of MRI, CT and Pulmonary Function Tests for Early Detection of Chronic Lung Allograft Dysfunction

Status
Recruiting
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sean Fain · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients.

Detailed description

This studies purpose is to confirm the efficacy and efficiency of using OE-MRI and MRI with hyperpolarized gas techniques and Iodinated contrast CT scan, this will enhance understanding of CLAD pathophysiology. Moreover, this project is foundational to performing additional studies to establish if novel MRI imaging can serve as an objective confirmatory diagnostic tool for CLAD in post-transplant patients. This observational imaging study will use 3T UTE MRI with varying oxygen levels (room air vs. 100% oxygen) to evaluate lung ventilation using oxygen enhanced imaging, in 50 healthy normal subjects (age 18-80). Subjects will have vital signs taken, complete questionnaires and have pulmonary function test (spirometry) done, Iodinated contrast CT scan and standard of care CT scans, in addition to one MRI session that will include 6 series of scans. The MRI scans will be taken in supine position (laying on back) and include breathing room air and 100% oxygen. OE-MRI will be done in addition to MRI scans with Xenon-129.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSpirometrySpirometry measures lung function, specifically the amount and/or speed of air that can be inhaled and exhaled.
DIAGNOSTIC_TESTContrast Lung Computed Tomography (CT) ScanCT scan of the lungs using contrast
DIAGNOSTIC_TESTOxygen enhanced magnetic resonance imaging (OE-MRI) ScanMRI will be taken while subject is lying on their back breathing 100% oxygen.
DRUG129Xe MRI scansMRI will be taken while subject is lying on their back breathing room oxygen and taking a breath of 129Xe and holding it for a few seconds.

Timeline

Start date
2025-03-20
Primary completion
2028-09-01
Completion
2028-09-01
First posted
2024-05-09
Last updated
2025-03-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06406777. Inclusion in this directory is not an endorsement.